top of page

Past Webinar

Webinar: Exploring VerAvanti's Next-Generation Intravascular Imaging Technolo

We hosted an information session on the Early Access Program. Our team, along with our Chief Medical Officer Dr. Luis Savastano, provided a comprehensive overview of our breakthrough technology.

SPEAKER:

Dr. Luis Savastano

DATE:

August 18, 2025

TIME:

9:00 AM (PDT - USA) | 12:00 PM (EDT - USA) | 6:00 PM (CET - Europe)

LOCATION:

Online

Webinar Overview


VerAvanti hosted a webinar featuring Dr. Luis Savastano to introduce our Scanning Fiber Endoscope (SFE) platform and its approach to intravascular imaging.

The session explored the potential of real-time, forward-viewing, full-color visualization and the ongoing research behind VerAvanti's imaging technology.


About the Speaker


Dr. Luis Savastano is a surgeon-scientist, inventor, and neuroendovascular specialist at the University of California, San Francisco (UCSF).

As Chief Medical Officer at VerAvanti, Dr. Savastano plays a key role in shaping the company's clinical research and validation strategy. His research focuses on advancing imaging technologies and exploring their potential applications in vascular and neurovascular medicine.


Webinar Highlights


This webinar explored:

  • SFE Technology: An introduction to VerAvanti's scanning fiber imaging platform and its development.

  • Forward-Viewing Visualization: The technology behind real-time, full-color imaging from a compact fiber-optic system.

  • Potential Clinical Applications: How forward-looking imaging is being explored to address visualization challenges in vascular procedures.

  • Research and Innovation: VerAvanti's ongoing development efforts and research directions.


About VerAvanti


VerAvanti is developing advanced intravascular imaging technology designed to provide real-time, forward-looking, full-color visualization.


Our first product, Luce, is a single-use imaging catheter and console designed to show what lies directly ahead of the catheter. Our Scanning Fiber Endoscope (SFE) platform is being developed to expand imaging capabilities through compact fiber-optic technology.

VerAvanti's imaging systems are investigational devices under development and have not been cleared or approved by the U.S. Food and Drug Administration.


Explore Our Research & Technology

https://www.veravanti.com/tech

bottom of page